EndocrinologyPhysiologyPeer-reviewed journal article
Adrenal rather than central dysfunction limits HPA axis recovery after chronic glucocorticoid treatment in male mice
Lindsey S. GastoniD, Brenna Jorgensen, Hannah FriedmaniD, Marc Samuel ShermaniD, Joseph A. MajzoubiD
Abstract
Glucocorticoid-induced adrenal insufficiency (GIAI) can persist for months after discontinuation of chronic corticosteroid therapy, placing patients at risk for life-threatening adrenal crises. This prolonged suppression has been attributed primarily to delayed restoration of hypothalamic-pituitary signaling based on indirect measures of central axis activity. To identify the rate-limiting site of hypothalamic-pituitary-adrenal (HPA) axis recovery, we evaluated the timing of functional and histologic recovery at each node of the axis following 8 weeks of dexamethasone (DEX) treatment in adult, male mice. DEX administration fully suppressed HPA axis activity. Unexpectedly, within one week of DEX withdrawal, hypothalamic Crh mRNA and plasma ACTH rebounded above control levels, whereas corticosterone (CORT) remained suppressed for an additional seven weeks. DEX-treated adrenals were markedly atrophic and contained large clusters of lipid-filled macrophages. Even after adjusting for macrophage content, CORT secretion was disproportionately low relative to the remaining adrenocortical cell mass despite supraphysiologic ACTH stimulation. The adrenal is thus the principal site of post-withdrawal GIAI, involving adrenocortical cell loss and a superimposed defect in steroidogenesis. We next tested whether preserving adrenal trophic signaling during glucocorticoid exposure could prevent GIAI. Adrenal function recovered more slowly in mice treated with DEX and daily cosyntropin (a synthetic ACTH analog) compared to those treated with DEX alone. In contrast, mice with non-suppressible endogenous ACTH due to targeted hypothalamic deletion of the glucocorticoid receptor maintained normal adrenal architecture and steroidogenic capacity despite prolonged DEX treatment. Pharmacologic treatments that mimic sustained trophic signaling to the adrenal during chronic glucocorticoid treatment may thus prevent GIAI.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 1
- FWCI
- 4.98
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dissection of the corticotroph transcriptome in a mouse model of glucocorticoid-induced suppression of the HPA axis
N. Romano, P. Duncan, … T. J. G. Chambers·bioRxiv·Jul 29, 2020
- Succinate mediates inflammation-induced adrenocortical dysfunction
I. Mateska, A. Witt, … V. I. Alexaki·bioRxiv·Apr 29, 2022
- Absent, but not glucocorticoid-modulated, corticotropin-releasing hormone (Crh) regulates anxiety-like behaviors in mice
Hannah Friedman, Lindsey S. Gaston, … Joseph A. Majzoub·bioRxiv·Sep 23, 2024
- Glucocorticoids desensitize hypothalamic CRH neurons to norepinephrine and somatic stress activation via rapid nitrosylation-dependent regulation of α1 adrenoreceptor trafficking
Grant L. Weiss, Laura M. Harrison, … Jeffrey G. Tasker·bioRxiv·Jul 29, 2024
- Hypothalamic glucocorticoid receptor in CRF neurons is essential for HPA axis habituation to repeated stressor
Carine Dournes, Julien Dine, … Alon Chen·bioRxiv·Nov 30, 2020
- Cortisol levels adter cold exposure are independent of adrenocorticotropic hormone stimulation
A. M. Shida, T. Ikeda, … T. Ishikawa·bioRxiv·Jun 13, 2019